These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 14668796)

  • 1. Epidermal growth factor receptor-dependent activation of Gab1 is involved in ErbB-2-mediated mammary tumor progression.
    Gillgrass A; Cardiff RD; Sharan N; Kannan S; Muller WJ
    Oncogene; 2003 Dec; 22(57):9151-5. PubMed ID: 14668796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation and function of the epidermal growth factor receptor and erbB-2 during mammary gland morphogenesis.
    Sebastian J; Richards RG; Walker MP; Wiesen JF; Werb Z; Derynck R; Hom YK; Cunha GR; DiAugustine RP
    Cell Growth Differ; 1998 Sep; 9(9):777-85. PubMed ID: 9751121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The extracellular region of heregulin is sufficient to promote mammary gland proliferation and tumorigenesis but not apoptosis.
    Weinstein EJ; Leder P
    Cancer Res; 2000 Jul; 60(14):3856-61. PubMed ID: 10919660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NDF/heregulin induces persistence of terminal end buds and adenocarcinomas in the mammary glands of transgenic mice.
    Krane IM; Leder P
    Oncogene; 1996 Apr; 12(8):1781-8. PubMed ID: 8622899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the epidermal growth factor receptor family in mammary tumorigenesis and metastasis.
    Kim H; Muller WJ
    Exp Cell Res; 1999 Nov; 253(1):78-87. PubMed ID: 10579913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumors initiated by constitutive Cdk2 activation exhibit transforming growth factor beta resistance and acquire paracrine mitogenic stimulation during progression.
    Corsino P; Davis B; Law M; Chytil A; Forrester E; Nørgaard P; Teoh N; Law B
    Cancer Res; 2007 Apr; 67(7):3135-44. PubMed ID: 17409420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The matrix metalloproteinase matrilysin influences early-stage mammary tumorigenesis.
    Rudolph-Owen LA; Chan R; Muller WJ; Matrisian LM
    Cancer Res; 1998 Dec; 58(23):5500-6. PubMed ID: 9850086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AEE788: a dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity.
    Traxler P; Allegrini PR; Brandt R; Brueggen J; Cozens R; Fabbro D; Grosios K; Lane HA; McSheehy P; Mestan J; Meyer T; Tang C; Wartmann M; Wood J; Caravatti G
    Cancer Res; 2004 Jul; 64(14):4931-41. PubMed ID: 15256466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.
    Huang Y; Li X; Jiang J; Frank SJ
    Oncogene; 2006 Dec; 25(58):7565-76. PubMed ID: 16785991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Active signaling by Neu in transgenic mice.
    DiGiovanna MP; Lerman MA; Coffey RJ; Muller WJ; Cardiff RD; Stern DF
    Oncogene; 1998 Oct; 17(14):1877-84. PubMed ID: 9778054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
    Cabodi S; Tinnirello A; Di Stefano P; Bisarò B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P
    Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of Notch1 in the development of mouse mammary tumors.
    Diévart A; Beaulieu N; Jolicoeur P
    Oncogene; 1999 Oct; 18(44):5973-81. PubMed ID: 10557086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mammary gland specific hEGF receptor transgene expression induces neoplasia and inhibits differentiation.
    Brandt R; Eisenbrandt R; Leenders F; Zschiesche W; Binas B; Juergensen C; Theuring F
    Oncogene; 2000 Apr; 19(17):2129-37. PubMed ID: 10815804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of simultaneous inhibition of epidermal growth factor receptor and cyclooxygenase-2 in HER-2/neu-positive breast cancer.
    Lanza-Jacoby S; Burd R; Rosato FE; McGuire K; Little J; Nougbilly N; Miller S
    Clin Cancer Res; 2006 Oct; 12(20 Pt 1):6161-9. PubMed ID: 17062693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal growth factor signaling mediated by grb2 associated binder1 is required for the spatiotemporally regulated proliferation of olig2-expressing progenitors in the embryonic spinal cord.
    Hayakawa-Yano Y; Nishida K; Fukami S; Gotoh Y; Hirano T; Nakagawa T; Shimazaki T; Okano H
    Stem Cells; 2007 Jun; 25(6):1410-22. PubMed ID: 17332510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenge with mammary tumor cells expressing MHC class II and CD80 prevents the development of spontaneously arising tumors in MMTV-neu transgenic mice.
    Jabrane-Ferrat N; Campbell MJ; Esserman LJ; Peterlin BM
    Cancer Gene Ther; 2006 Nov; 13(11):1002-10. PubMed ID: 16841083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of epidermal growth factor receptor expression to ErbB-2 signaling activity and prognosis in breast cancer patients.
    DiGiovanna MP; Stern DF; Edgerton SM; Whalen SG; Moore D; Thor AD
    J Clin Oncol; 2005 Feb; 23(6):1152-60. PubMed ID: 15718311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Y-box-binding protein 1 confers EGF independence to human mammary epithelial cells.
    Berquin IM; Pang B; Dziubinski ML; Scott LM; Chen YQ; Nolan GP; Ethier SP
    Oncogene; 2005 Apr; 24(19):3177-86. PubMed ID: 15735691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Gab2 in mammary tumorigenesis and metastasis.
    Ke Y; Wu D; Princen F; Nguyen T; Pang Y; Lesperance J; Muller WJ; Oshima RG; Feng GS
    Oncogene; 2007 Jul; 26(34):4951-60. PubMed ID: 17310989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic modulation of neu proto-oncogene-induced mammary tumorigenesis.
    Rowse GJ; Ritland SR; Gendler SJ
    Cancer Res; 1998 Jun; 58(12):2675-9. PubMed ID: 9635596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.